China Wah Yan Healthcare Limited announced that on 7 June 2016, the Group entered into the sale and purchase agreement with Dr. Chan. Following completion of the SPA, the Target Company will become a wholly-owned subsidiary of the Company and Dr. Chan will be appointed as the managing director of the Target Company and the chief executive officer of the Company.